4170 logo

Vectorite Biomedical Inc. Stock Price

TPEX:4170 Community·NT$610.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4170 Share Price Performance

NT$13.95
-0.25 (-1.76%)
NT$13.95
-0.25 (-1.76%)
Price NT$13.95

4170 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
0 Rewards

Vectorite Biomedical Inc. Key Details

NT$67.9m

Revenue

NT$40.9m

Cost of Revenue

NT$27.0m

Gross Profit

NT$50.2m

Other Expenses

-NT$23.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.53
39.77%
-34.16%
0%
View Full Analysis

About 4170

Founded
2004
Employees
n/a
CEO
Kechang Ou
WebsiteView website
www.vectorite.com.tw

Vectorite Biomedical Inc. engages in the research and development of biotechnology in Taiwan and internationally. It is involved in cell preparation product manufacturing; and collection and storage of immune cells. The company’s products are used in the field of infectious diseases and inflammation, cancer, oncology. Vectorite Biomedical Inc. was incorporated in 2004 and is based in New Taipei City, Taiwan.

Recent 4170 News & Updates

Recent updates

No updates